APA (7th ed.) Citation

R, S., Y, L. P., F, P., E, B., L, N., A, F., . . . M, P. (2026). Heterozygous loss-of-function alleles associate the conserved 3'-5' exoribonuclease EXOSC10 with hypersensitivity to the anticancer drug 5-fluorouracil. Molecular oncology. https://doi.org/10.1002/1878-0261.70239

Chicago Style (17th ed.) Citation

R, Sain, et al. "Heterozygous Loss-of-function Alleles Associate the Conserved 3'-5' Exoribonuclease EXOSC10 with Hypersensitivity to the Anticancer Drug 5-fluorouracil." Molecular Oncology 2026. https://doi.org/10.1002/1878-0261.70239.

MLA (9th ed.) Citation

R, Sain, et al. "Heterozygous Loss-of-function Alleles Associate the Conserved 3'-5' Exoribonuclease EXOSC10 with Hypersensitivity to the Anticancer Drug 5-fluorouracil." Molecular Oncology, 2026, https://doi.org/10.1002/1878-0261.70239.